Still very much undervalued based on the track record profit the company could make at whatever almond prices. And not only so, the company's Food Division will be a potential game changer in near future. If it can make $10M EBITDA this year, that will be delivering 2 years in advance of original target. What if it becomes $20M EBITDA in near future?!
I believe that significant re-rating of the stock will happen soon amongst the analysts..
- Forums
- ASX - By Stock
- Shorters last attempt...
Still very much undervalued based on the track record profit the...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.64 |
Change
-0.060(1.62%) |
Mkt cap ! $447.9M |
Open | High | Low | Value | Volume |
$3.73 | $3.78 | $3.64 | $232.9K | 63.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1067 | $3.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.65 | 570 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1067 | 3.640 |
4 | 2488 | 3.630 |
4 | 3174 | 3.620 |
4 | 6000 | 3.610 |
4 | 5246 | 3.600 |
Price($) | Vol. | No. |
---|---|---|
3.650 | 693 | 15 |
3.660 | 1265 | 5 |
3.670 | 3157 | 4 |
3.680 | 7436 | 6 |
3.690 | 970 | 3 |
Last trade - 12.06pm 04/07/2024 (20 minute delay) ? |
Featured News
SHV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online